HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Warnings, Earnings, Racing: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Armada Nutrition response on 483 observations inadequate; Herbalife ‘entering new chapter’; Mannatech turns around from year-ago loss; and Prevagen goes racing.

You may also be interested in...

Herbalife Forecasts Smoother Sailing Following FTC Settlement Bumps

Despite a first-quarter slump, changes being implemented in Herbalife's North American operations, some required by under is 2016 settlement an FTC investigation, point to better results for the rest of 2017, the nutrition and weight loss supplement direct seller says.

New York AG And FTC Target Prevagen Memory Claims

FTC and New York Attorney General file a lawsuit dietary alleging supplement marketer Quincy Bioscience preyed on elderly consumers with a multi-channel ad campaign claims its supplement Prevagen boosted memory.

Herbalife CEO Plans Exit With FTC-Required Changes Underway

The firm with independent distributors selling nutritional and weight loss products around the world reports third-quarter net income of $87.7m, off 6.3% from the year-ago quarter.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts